Africa Dialysis Market Analysis Sample Report

Africa Dialysis
Market Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of the Africa Dialysis Market
and a forecast for its development in the medium and long term. It provides
a comprehensive overview of the market value, dynamics, segmentation,
main players, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the Africa Dialysis
Market, and offers unmatched value, accuracy, and expert insights

3
A Sample Report on Africa Dialysis Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology

4
Table of Content
CONTENT PG. NO.
1. Africa Dialysis Overview 12-26
1.1. Overview
1.2. Africa Overview
1.3. Economic Overview: Africa
1.4. Dialysis Market in Africa
1.5. Healthcare Service Market in Africa
1.6. Healthcare Scenario in Africa
1.7. Health Insurance Coverage: Africa
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 27-32
2.1 Market size and forecasts (Excel and Methodology)

5
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. By Product Type
2.2.2. By Application
2.2.3. By End Use
3. Market Dynamics 33-37
3.1. Market Growth Drivers
3.1.1. Growing Burden of Chronic Kidney Disease (CKD)
3.1.2. Limited Infrastructure for Kidney Transplantation
3.1.3. Rising Incidence of Diabetes and Hypertension
3.2. Market Restraints
3.2.1. Affordability and Financial Constraints
3.2.2. Lack of Skilled Healthcare Professionals

6
Table of Content
CONTENT PG. NO.
3.2.3. Limited Awareness and Education
4. Competitive Landscape 38-47
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. Fresenius Medical Care AG & Co. KGaA
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)
4.2.2. Braun Melsungen AG
4.2.2.1. Overview

7
Table of Content
CONTENT PG. NO.
4.2.3. Nairobi X-Ray Supplies Ltd.
4.2.3.1. Overview
4.2.4. Adcem Pharmaceutical Limited
4.2.4.1. Overview

8
Table of Content
CONTENT PG. NO.
4.2.5. Life Healthcare
4.2.5.1. Overview
4.2.6. Izinso Dialysis Service
4.2.6.1. Overview

9
Table of Content
CONTENT PG. NO.
4.2.7. Baxter International Inc.
4.2.7.1. Overview
4.2.8. Nipro Corporation:
4.2.8.1. Overview

10
Table of Content
CONTENT PG. NO.
4.2.9. DaVita Inc
4.2.9.1. Overview
4.2.10. Diaverum
4.2.10.1. Overview

11
Table of Content
CONTENT PG. NO.
5. Reimbursement Scenario -Africa 48-50
5.1 Reimbursement Regulation by Government
6. Methodology & Scope 51-55

Africa Dialysis Market Analysis
1. Dialysis Overview

13
1.1 Statistics at a Glance: The Burden of Chronic Kidney Diseases in the World
Prevalence of CKD Worldwide ▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
13.4%
global estimated prevalence
of chronic kidney disease
(CKD) prevalence
4.902 and 7.083 Mn
patients with end-stage kidney
disease (ESKD) needing renal
replacement therapy globally
CKD is the 10th
cause of years of life lost
worldwide
CKD is the 10th
10th cause of disability-
adjusted life years in both
sexes combined
>10%
Of general population affected
by Chronic kidney disease is a
progressive condition worldwide
CKD is the 8th
cause of mortality globally
70%
of patients will live in low-
income countries, including
sub-Saharan Africa By 2030,
more than 70% of ESKD

14
1.1 Statistics at a Glance: The Burden of Dialysis in the World (continued)
North America
~ Market Size of
$XX Bn
Europe
~Revenue to reach
$XX Bn by 2027
Asia
-Fastest CAGR
Africa
~Market Size of
$XX Bn
Middle East
Market
~$XX Bn Market
Illustrative

15
1.2 Africa Overview
1.39 Bn
Is the total
population of Africa
19
Is the median age
in Africa
$3.14 Tn
Gross domestic
product (GDP) of
Africa
$2,260
GDP per capita
of Africa
▪ Please be aware that this sample report is
report
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
interest

16
1.3 Economic Overview: Africa
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of Africa, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of Africa, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
49%
Female
51%
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative

17
1.4 Statistics at a Glance: Burden of chronic kidney disease on the Africa
North Africa 6.1%
West Africa 19.8%
Central Africa 16%
East Africa 14.4%
Southern Africa 10.4%
Prevalence of CKD in the general population of Africa Region
▪ Prevalence of CKD in the general
population by region. The overall
prevalence in the general population was
15.8%
understanding of the epidemiology of the
CKD in Africa region
interest

18
1.4 Statistics at a Glance: Chronic Kidney Diseases (CKD) in Africa
CKD Epidemiology in Africa
▪ Please be aware that this sample report
is intended to provide you with a brief
analysis that will be presented in the
final report
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in Africa
information that you are seeking, you
will need to purchase the final report
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
10.1% to 15.8%
Is pooled
prevalence of CKD
in general and high-
risk populations in
Africa
12% and 16%
Is the pooled
prevalence of CKD
in Southern Africa
and Central Africa
respectively
4%, and 11%
Is the pooled
prevalence of CKD
in North Africa and
East Africa
respectively
5.6%
Is the pooled
prevalence of CKD in
those with HIV/AIDS
24.7%
Is the pooled
those with in those
with diabetes mellitus
34.5%
Is the pooled
those with in those
with hypertension

19
1.5 Healthcare Services in Africa
XX XX XX XX XX XX XX XX XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Africa Healthcare Services Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall healthcare services market in Africa, which includes the market size, current trends
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
Illustrative

20
1.6 Healthcare Scenario in Africa
▪ Chronic kidney diseases (CKD) are a growing health concern in Africa, fueled by factors such as the increasing prevalence of risk factors
like diabetes and hypertension
▪ Limited access to screening and early detection programs contributes to late-stage CKD diagnoses in many African countries.
▪ Dialysis treatment, including hemodialysis and peritoneal dialysis, is the primary therapy for end-stage renal disease (ESRD) in Africa,
but access to dialysis facilities and services is limited, particularly in rural areas
▪ Kidney transplantation, a long-term solution for ESRD, faces significant challenges in Africa, including a shortage of suitable organ
donors and limited transplant infrastructure
▪ Affordability and financial constraints pose barriers to accessing dialysis treatment and other necessary medications and services for
CKD patients in Africa
May 2021
▪ DaVita Inc. expanded its home kidney care program to include the HomeChoice Claria Automated Peritoneal
Dialysis (APD) system enabled by Sharesource remote patient monitoring from Baxter International Inc
▪ This new technology further enhanced DaVita's home dialysis program and is another important step forward to
enable more patients to choose to treat their kidney failure at home
May 2021
▪ May 2021, Mar Cor Purification, Inc., a Cantel Medical Corp. business, announced the launch of the EON Portable
Dialysis Water System
▪ Portable water purification device uses reverse osmosis (RO) to remove organic and inorganic substances and
microbial contaminants from water that feeds into hemodialysis machines to treat hemodialysis patients or related
therapies. The water system quickly delivers and efficiently produces medical-grade water for single-patient
hemodialysis treatments in hospitals, clinics, skilled nursing centers, and home environments
A few recent developments related to hemodialysis and peritoneal dialysis are mentioned below

21
1.6 Healthcare Scenario: Patient journey with Dialysis
Nephrologist
▪ Prevention and
management of CKD
▪ Delay and prepare for
dialysis
Early Care and
Prevention
Primary care Clinician
referral
Transition into Dialysis
Hospitalization
Vascular access
or peritoneal
Dialysis catheter
placement
Dialysis Facility
• Education
• Modality Selection
• Insurance Initiation
facility
selection
unplanned
entry
Ongoing care coordination
In-Center Dialysis
modality
switch
Home Dialysis
• Peritoneal Dialysis
• Hemodialysis
acute care
episode
acute care
episode
Transplant
center
assessment
for transplant
Hospital
ongoing transplant management and care
planned
entry
failed
transplant

22
1.7 Health Insurance Coverage: Africa
1.0
18.9
18.4
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Medicaid
Medicare
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care
(1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
Medicare 58,541 60,226 0.5
Medicaid 58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative

23
1.8 Budget of Africa Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
Medicaid $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
Medicaid 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative

24
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative

25
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
W. L. Gore &
Associates, Inc
acquisition of
InnAVasc Medical, Inc
Acquisition - August 2022
▪ W. L. Gore & Associates, Inc. (Gore) a global material science
company dedicated to transforming industries and improving
lives, announced the acquisition of InnAVasc Medical, Inc., a
privately-held medical technology company focused on
advancing care for patients with end stage renal disease who
utilize graft circuits for dialysis treatment
M42 buys dialysis
group Diaverum
Acquisition - April 2023
▪ M42 buys European dialysis group Diaverum
▪ Abu Dhabi’s newest tech-enabled healthcare company, M42,
has made its first investment with the acquisition of Diaverum, a
global renal care service provider
Latest Deals - Global

26
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Merger March 2023
Merger Jan 2023
Latest Deals In Africa
Illustrative

2. Market Size and Forecasting

28
2.1 Market size and forecasts (Excel and Methodology)
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Africa Dialysis Market Forecast, 2022-2030 (in $Bn)
final report
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Africa Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Africa Market Size (Bn $) 61 74 84 87 91 95 99 106
Illustrative

29
2.2 Snapshot of Dialysis Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the Africa Dialysis Market
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
By Product Type By Application By End Use
Hemodialysis (HD)
Equipment
Peritoneal Dialysis
(PD) Equipment
Concentrates and
Solutions
Catheters and
Tubings
Other Products
Hemodialysis
Contract Research
Organizations
(CROs) Peritoneal
Dialysis
In-Center Dialysis
Settings
Home Care Settings

30
Africa Dialysis Market Share, By Product Type (2022)
Hemodialysis
(HD) Equipment
Peritoneal
Dialysis (PD)
Equipment
Concentrates
and Solutions
Catheters and
Tubings
Other Products
▪ Hemodialysis market in Africa is a
significant component of the overall
dialysis market
final report
2.2.1 Market Segmentation: By Product Type
Illustrative

31
Africa Dialysis Market Share, By Application Type (2022)
Hemodialysis
Contract
Research
Organizations
(CROs)
Peritoneal
Dialysis
2.2.2 Market Segmentation: By Application Type
▪ Hemolialysis market in Africa is a
significant component of the overall
dialysis market
final report
Illustrative

32
Africa Dialysis Market Share, By End User (2022)
In-Center
Dialysis Settings
Home Care
Settings
2.2.3 Market Segmentation: By End User
▪ In-center dialysis settings have the
maximum market share in Africa
dialysis market with approximately xx%
final report
Illustrative

3. Market Dynamics

34
3.1 Market growth drivers
▪ Chronic kidney disease (CKD) is a major cause of morbidity and mortality
in Africa. CKD is associated with 35.8 Mn disability-adjusted life years
(DALYs), one-third of which is attributed to diabetic kidney disease (DKD)
▪ Overall prevalence was 15.8% for CKD stages 1–5 and 4.6% for CKD
stages 3–5 in the general population
▪ Many African countries are currently undergoing rapid epidemiological
transitions and are confronted with the double burden of communicable
and non-communicable diseases, in part driven by the adoption of
western lifestyles, changes in the built environment, and the rapid
urbanization
▪ This dual burden has led to a consequential rise in the number of people
affected by CKD on the African continent
▪ Given the constant rise in its risk factors in Africa , CKD is increasingly
recognized as a major public health threat, against a background of
limited access to dialysis and renal replacement therapy (RRT)
▪ Dialysis serves as a critical treatment option for end-stage renal disease
(ESRD) patients, driving the demand for dialysis services and products
2010 2022 2030
3.1.1 The International Society of Nephrology (ISN) Global Health Atlas survey for Africa estimated the prevalence of
CKD in Africa to be 4.6-10.1% in Africa
Chronic Kidney Disease Burden in Africa

35
3.1 Market growth drivers (continued)
3.1.2 Only 7 African states including Algeria, Côte d’Ivoire, Ethiopia, Kenya, Namibia, Nigeria, and Uganda have
facilities for kidney transplantation. In fact, the entire African continent has just 35 centers for kidney transplantation
▪ Kidney transplantation is the preferred treatment for ESRD, however
limited infrastructure for transplantation pose challenges in Africa. As
a result, dialysis becomes the primary modality for renal replacement
therapy in the absence of viable transplant options
▪ Senegal is a country in West Africa bordered by the Atlantic Ocean to
the west, Mauritania to the north, Mali to the east, Guinea and
Guinea-Bissau to the south, and the Gambia located within
▪ There is a disparity in the distribution of the population between the
14 administrative regions; Dakar, the capital, constitutes the smallest
area and includes 23% of the total population and 75% of the urban
population, whereas the southeastern regions house only 6% of the
total population
▪ In the absence of kidney transplant options, dialysis plays a crucial
role in providing lifesaving treatment to individuals with ESRD, which
creates a sustained demand for dialysis treatment, leading to the
growth of dialysis centers and the dialysis market as a whole
Distribution of dialysis centers across regions of Senegal. Functional dialysis centers
are shown in blue and dialysis centers under construction are shown in orange

36
3.1 Market growth drivers (continued)
3.1.3 Increasing prevalence of hypertension and diabetes conditions in the African population contributes to a
higher risk of CKD development which results in a greater need for dialysis services to manage ESRD
▪ Hypertension is a leading cause of CKD in Africa, ranging from 25% in Senegal to 29.8% in Nigeria, 45.6% in South Africa, and 48.7%
in Ghana, especially in black patients
▪ Hypertension affects about 25% of the adult population and is the cause of ESRD in 21% of patients on RRT in South Africa
▪ Malignant hypertension was an important cause of morbidity and mortality among urban black South Africans, with hypertension
accounting for 16% of all hospital admissions, but seems to be of lesser frequency in the present era
▪ Diabetes mellitus affects 9.4 Mn people in Africa. The estimated increase in diabetes mellitus in Africa is anticipated to be 12.7 Mn, an
increase of 140%, by 2025.
▪ Prevalence of diabetic nephropathy is estimated to be 6–16% in Sub Saharan Africa (SSA), with the prevalence of ESRD due to
diabetes increasing in some regions of SSA
▪ These conditions can damage the kidneys over time, leading to the development and progression of CKD. As CKD advances to end-
stage renal disease (ESRD), dialysis becomes a crucial treatment option to sustain life
▪ Increasing prevalence of diabetes and hypertension directly contributes to a larger pool of individuals with ESRD who require dialysis,
driving the demand for dialysis services

37
3.2 Market restraints
3.2.1 Affordability is a
significant restraint in
the Africa dialysis
market
▪ Annual cost per hemodialysis patient
are calculated as US$ 7000 in South
Africa and range between US$
25,000-55,000 in Nigeria
▪ Peritoneal dialysis (PD) costs range
between US$ 7000 in Egypt and
between US$ 20,000-49,000 in
Nigeria
▪ Cost of dialysis per patient per year
is tremendous for a least developed
country like Tanzania where
resources are limited and materials
have to be imported at high cost
3.2.2 shortage of skilled
professionals of dialysis care
is a significant restraint in the
Africa dialysis market
▪ There remains a continuing ‘brain
drain’ of healthcare workers from
Africa to more affluent regions
▪ There are large rural areas of Africa
that have no health professionals to
serve these populations
▪ Africa has the lowest numbers of
physicians and nurses to serve its
population
▪ Distribution of physicians and
nephrologists in a spectrum of
African countries and their
corresponding rates of RRT
▪ It is evident that there are no
nephrologists in many parts of Africa
3.2.3 Lack of awareness about
kidney diseases, and available
treatment options restraining the
Africa dialysis market
▪ Awareness level of the Nigerian on
kidney functions and diseases was
poor
▪ 60% of the Nigerian had a poor
knowledge of kidney functions and
diseas
▪ Insufficient education and
awareness campaigns among the
general population, healthcare
professionals, and policymakers can
result in delayed diagnoses, late
referrals to dialysis centers, and
underutilization of dialysis services
Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth.

4. Competitive Landscape

39
4.1 Major Market Share
▪ Africa dialysis market is a highly
competitive space, with many companies
developing and marketing cancer
treatments
▪ Some of the top companies in Africa
dialysis market based on revenue and
market share include
interest
Revenue of Major players in Africa Dialysis Market ($ Mn)
XX
Company10
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9

40
4.1 Key Company Profile
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
1 Fresenius Medical Care AG &
Co. KGaA
3 Nairobi X-Ray Supplies Ltd.
5 Life Healthcare
7 Baxter International Inc.
9 DaVita Inc
2 Braun Melsungen AG
4
Adcem Pharmaceutical
Limited
6 Izinso Dialysis Service
8 Nipro Corporation
Diaverum
10
Key Note:

41
4.2.1 Fresenius Medical Care AG & Co. KGaA
Founded in: 1996
HQ: Bad Homburg, Germany
Type: Private
Revenue: $20.86 Bn (2022)
Website: freseniusmedicalcare.co.in
▪ Fresenius Medical Care AG & Co KGaA, is an integrated dialysis
company
▪ It provides dialysis care services and products to individuals with
chronic kidney failure
▪ Company develops and manufactures a comprehensive range of
dialysis machines, systems, and disposable products
▪ It provides dialysis treatment at its clinics and sells its products to
other dialysis service providers
▪ It conducts operations through subsidiaries in Europe, the Middle
East, Africa, the Americas and Asia-Pacific
Company at Glance
➢ 42 Production Site
➢ 4,100 Dialysis Sites
➢ 128,000 Employees
➢ 344,000 Patients
➢ 52 Treatments
Fresenius Medical Care Services
Dialysis Machines Clinical Services Transplantation Support
Dialysis Consumables Dialysis Technology Solutions Quality Assurance
Dialysis Clinics and
Centers
Education and Training Water Treatment Solutions
Home Dialysis Solutions Research and Innovation
Remote Monitoring and
Telehealth Solutions
Renal Pharmaceuticals Renal Consulting Services Patient Support Programs
Recent News/ Press Release
May 2023,Fresenius Medical Care signs Charta der
Vielfalt, German Diversity Charter
May 2023, Fresenius Medical Care wins CIO 100
Award for novel tool to predict intradialytic
hypotension
December 2022, Fresenius Medical Care included in
Dow Jones Sustainability World Index

42
4.2.1 Fresenius Medical Care AG & Co. KGaA (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Ivenix, Inc. acquired by
Fresenius Kabi
Acquisition $240 Mn
March
2022
▪ Ivenix, Inc. announced that it has entered into a definitive
agreement to be acquired by Fresenius Kabi, a global health care
leader specializing in lifesaving medicines and technologies for
infusion, transfusion and clinical nutrition
▪ Ivenix’s advanced infusion system combined with Fresenius Kabi’s
intravenous fluids and infusion therapy offerings will bring a
comprehensive portfolio of infusion products to US
▪ Purchase price will be a combination of $240 Mn upfront payment
and milestone payments linked to achievements of commercial and
operating targets
ExThera Medical
Agreement with
Fresenius Medical
Care
Partnership - Aug 2022
▪ ExThera Medical and Fresenius Medical Care, the world’s leading
provider of products and services for individuals with renal
diseases, announced the expanded distribution of ExThera’s
Seraph® 100 Microbind® Affinity Blood Filter in Mexico. In 2021,
ExThera Medical and Fresenius Medical Care partnered to
distribute
Latest Deals - Mergers and Acquisitions

43
4.2.1 Fresenius Medical Care AG & Co. KGaA (continued)
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
79%
21%
Healthcare Services Healthcare Products
2022
Total
$20.66 Bn
70%
15%
11%
4%
North America
Europe, Middle East, and Africa
Asia-Pacific
Latin America
2022
Total
$20.66 Bn
Revenue by Division Revenue by Region

44
4.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for Cancer Recent Activity / Press Coverage
Illustrative

45
4.2.2 Company 2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
Illustrative

46
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
Illustrative

47
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

5. Reimbursement Scenario - Africa

49
5.1 Reimbursement Regulation by Nigerian Government
Kenya
▪ In Kenya, dialysis reimbursement and coverage are primarily facilitated through the National Hospital Insurance Fund (NHIF)
▪ NHIF is a government-run national health insurance scheme that provides health insurance coverage to Kenyan citizens.
▪ Under NHIF, dialysis is covered as part of the specialized services package for members with chronic renal failure. Members with
chronic renal failure can access dialysis treatment at designated healthcare facilities that have contracts with NHIF
▪ However, it's important to note that there may be certain limitations and criteria for eligibility and coverage
o For example, there may be a waiting period before coverage for dialysis treatment begins, and specific medical documentation
and assessments may be required to determine eligibility
Egypt
▪ In Egypt, dialysis treatment is covered under the national health insurance system. Main entity responsible for healthcare coverage
and reimbursement in Egypt is the Ministry of Health and Population (MOHP)
▪ The MOHP operates various health insurance programs, including the Health Insurance Organization (HIO) and the Ministry of
Finance Insurance Organization (MFIO)
▪ Under these health insurance programs, eligible individuals with chronic kidney disease (CKD) may be entitled to dialysis
reimbursement. The specific reimbursement rates, coverage criteria, and reimbursement process may vary depending on the
insurance program and the individual's circumstances
▪ To receive dialysis reimbursement, patients are generally required to undergo an evaluation and assessment by a specialized
medical committee. This committee determines the eligibility for reimbursement based on certain criteria, such as the severity of the
kidney disease, medical documentation, and financial assessments

50
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
▪ Public insurance in Nigeria is primarily provided through NHS aims to provide
affordable and accessible healthcare services to eligible individuals, including
coverage for dialysis treatment, through various benefit packages
 Private insurance plans may offer a range of coverage options, including dialysis
treatment, but the coverage and reimbursement policies can vary depending on the
specific plan and insurance provider.
▪ Reimbursement market trends in Nigeria indicate an increasing focus on expanding health insurance coverage and improving reimbursement processes for
healthcare services, including dialysis treatment
▪ There is a growing recognition of the importance of sustainable reimbursement models to ensure equitable access to quality healthcare and incentivize healthcare
providers to deliver efficient and effective services 38.9%
37.1%
35.6%
32.5%
31.5%
XX%
XX%
XX%
XX%
XX%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
XX XX XX XX XX
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
xx% xx% xx% xx% xx% xx% xx% GDP Growth (yoy)
xx% xx% xx% xx% xx% NA NA HC Spend Growth (yoy)

6. Methodology & Scope

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust

www.insights10.com
A large database of over 30,000 syndicated
market research reports in Categoryname and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions

Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com

Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com

Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Categoryname
(Diseases & Drugs)
Digital
Health
Medical
Devices
across various categories
Market Research Reports

FEATURED REPORTS FREE SAMPLE REPORTS
TRENDING TOPICS

1200+
Reports
Published
Annually
30000+
Life science
Market Research
Reports
22000+
Country
Specific
Reports
2000+
Rare & orphan
Disease
Reports
What makes us different?

Market Overview
Growth Drivers &
Growth Restraints
Market Segmentation
Market Share Factors Driving Future Growth
Reimbursement Scenario
Policy & Regulatory
Landscape
Key Company Profiles
Epidemiology &
Disease type
Competitive Landscape
insights on
which our
reports are
based
1
2
3
4
5
6
10
9
8
7
Table of Contents

Subscription
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database
Service
Primary
Research
Customized
Reports
Market Research
Reports
Our Services

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players

What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO

Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the US, India, Middle East
and APAC regions. His primary
area of interest is Customer and
Market Strategy, Market Access,
and Digital Health with special
focus on emerging markets like
Africa, Middle East and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research & marketing
professional with a progressive
experience of over 20 years in Life
Sciences, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Africa, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?

www.insights10.com
Thank you
We truly appreciate your business and
look forward to serving you.

Africa Dialysis Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to Africa Dialysis Market Analysis Sample Report

Similar to Africa Dialysis Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Africa Dialysis Market Analysis Sample Report